Error: Could not add to watchlist. X

Eventide Healthcare & Life Sciences Fund

+ Watchlist
ETAHX:US
NASDAQ GM
16.51
USD
0.66
3.84%
As of 09:29:30 ET on 02/05/2016.
Fund Type
Open-End Fund
52Wk Range
16.51 - 27.61
1 Yr Return
-20.71%
YTD Return
-30.51%
Previous Close
17.17
52Wk Range
16.51 - 27.61
1 Yr Return
-21.68%
YTD Return
-30.51%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 02/05/2016)
16.51
Total Assets (m USD) (on 02/04/2016)
286.424
Inception Date
12/27/2012
Last Dividend (on 12/22/2015)
0.293
Dividend Indicated Gross Yield
-
Fund Managers
FINNY GEORGE KURUVILLA
Front Load Fee
5.75%
Back Load Fee
0.00%
Redemption Fee
1.00%
12b-1 Fee
0.25%
Current Mgmt Fee
1.10%
Expense Ratio
1.55%
Top Fund Holdings
Name Position Value % of Fund
Fidelity Institutional Money M 62.17 m 62.17 m 17.66
Collegium Pharmaceutical Inc 533.60 k 11.80 m 3.35
Ultragenyx Pharmaceutical Inc 105.50 k 10.16 m 2.89
Neurocrine Biosciences Inc 246.10 k 9.79 m 2.78
DBV Technologies SA 241.50 k 8.59 m 2.44
BioMarin Pharmaceutical Inc 80.40 k 8.47 m 2.41
Dyax Corp 422.90 k 8.07 m 2.29
Portola Pharmaceuticals Inc 186.90 k 7.97 m 2.26
Kite Pharma Inc 140.00 k 7.80 m 2.21
Bluebird Bio Inc 90.80 k 7.77 m 2.21
Profile
Eventide Healthcare & Life Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund will invest at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences industries.
ADDRESS
Catalyst Funds
630-A Fitzwatertown Road
2nd Floor
Willow Grove, PA 19090-1904
PHONE
1-866-447-4228